Recovery of pituitary function after treatment with a targeted cytotoxic analog of luteinizing hormone-releasing hormone. (Q35997236)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9037068%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

title

Recovery of pituitary function after treatment with a targeted cytotoxic analog of luteinizing hormone-releasing hormone (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9037068%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

0 references

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9037068%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

author name string

M Kovacs

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9037068%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

A Nagy

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9037068%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

M Koppan

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9037068%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

K Groot

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9037068%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

language of work or name

English

0 references

publication date

1 February 1997

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9037068%20AND%20SRC:MED&resulttype=core&format=json

Proceedings of the National Academy of Sciences of the United States of America

1 November 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9037068%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

volume

94

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9037068%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

issue

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9037068%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

page(s)

1420-1425

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9037068%20AND%20SRC:MED&resulttype=core&format=json

Endocrine sequelae of cancer therapy

1 November 2019

cites work

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=19806

Cytotoxic analogs of luteinizing hormone-releasing hormone containing doxorubicin or 2-pyrrolinodoxorubicin, a derivative 500-1000 times more potent

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=19806

High yield conversion of doxorubicin to 2-pyrrolinodoxorubicin, an analog 500-1000 times more potent: structure-activity relationship of daunosamine-modified derivatives of doxorubicin

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=19806

Effect of luteinizing hormone-releasing hormone analogs containing cytotoxic radicals on the function of rat pituitary cells: tests in a long term superfusion system

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=19806

Hypothalamic hormones: from neuroendocrinology to cancer therapy.

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=19806

Inhibition of growth of OV-1063 human epithelial ovarian cancer xenografts in nude mice by treatment with luteinizing hormone-releasing hormone antagonist SB-75.

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=19806

Stereochemistry of Intercalation: Interaction of Daunomycin with DNA

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=19806

Targeted toxin therapy for the treatment of cancer

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=19806

Cell surface actions of adriamycin

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=19806

Gonadotropin-releasing hormone gene expression in MDA-MB-231 and ZR-75-1 breast carcinoma cell lines

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=19806

Present status of agonistic and antagonistic analogs of LH-RH in the treatment of advanced prostate cancer

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=19806

A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=19806

The effects of gonadotrophin releasing hormone analogues in prostate cancer are mediated through specific tumour receptors

2 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=19806

Research into fish diseases

11 July 2018

1 reference

Crossref

https://api.crossref.org/works/10.1073%2FPNAS.94.4.1420

Growth of human breast cancer cells inhibited by a luteinizing hormone-releasing hormone agonist

21 January 2018

1 reference

Crossref

https://api.crossref.org/works/10.1073%2FPNAS.94.4.1420

Inhibition of growth of experimental prostate cancer in rats by LH-RH analogs linked to cytotoxic radicals

21 January 2018

1 reference

12 December 2020

High affinity binding and direct antiproliferative effects of LHRH analogues in human ovarian cancer cell lines

1 reference

12 December 2020

High affinity binding and direct antiproliferative effects of luteinizing hormone-releasing hormone analogs in human endometrial cancer cell lines

1 reference

12 December 2020

The use of luteinizing hormone releasing hormone agonists and antagonists in gynaecological cancers

1 reference

12 December 2020

Effect of a cytotoxic analog of LH-RH (T-98) on the growth of estrogen-dependent MXT mouse mammary cancers: correlations between growth characteristics and EGF receptor content of tumors

1 reference

12 December 2020

Bioactivation as a model for drug design bioreductive alkylation

1 reference

12 December 2020

The anticancer agent adriamycin can be actively cytotoxic without entering cells

1 reference

12 December 2020

Receptors for luteinizing hormone-releasing hormone, somatostatin, prolactin, and epidermal growth factor in rat and human prostate cancers and in benign prostate hyperplasia

1 reference

12 December 2020

Characteristics and distribution of receptors for [D-TRP6]-luteinizing hormone-releasing hormone, somatostatin, epidermal growth factor, and sex steroids in 500 biopsy samples of human breast cancer

1 reference

12 December 2020

Identifiers

DOI

10.1073/PNAS.94.4.1420

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9037068%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

0 references

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9037068%20AND%20SRC:MED&resulttype=core&format=json

1 November 2019

1 reference